This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Mar;3(4):247-8.

doi: 10.1016/s1526-9655(11)70186-5.

Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies

Joan Bladé¹, Laura Rosiñol

Affiliations

PMID: 12672275
DOI: 10.1016/s1526-9655(11)70186-5

Editorial

Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies

Joan Bladé et al. Clin Lymphoma. 2003 Mar.

. 2003 Mar;3(4):247-8.

doi: 10.1016/s1526-9655(11)70186-5.

Authors

Joan Bladé¹, Laura Rosiñol

Affiliation

¹ Hospital Clinic Instituto de Investigaciones Biomédicas August Pi i Sunyer, Barcelona, Spain.

PMID: 12672275
DOI: 10.1016/s1526-9655(11)70186-5

No abstract available

PubMed Disclaimer

Comment on

Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.
Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V. Seldin DC, et al. Clin Lymphoma. 2003 Mar;3(4):241-6. doi: 10.3816/clm.2003.n.005. Clin Lymphoma. 2003. PMID: 12672274 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science